Case report: Cerebral amyloid angiopathy-related inflammation in a patient with granulomatosis with polyangiitis.
case report
cerebral amyloid angiopathy-related inflammation
granulomatosis with polyangiitis
magnetic resonance imaging
neuroinflammation amyloid
vasculitis
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2023
2023
Historique:
received:
15
08
2023
accepted:
17
10
2023
medline:
29
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
Cerebral amyloid angiopathy-related inflammation (CAA-ri) defines a subacute autoimmune encephalopathy, which is presumably caused by increased CSF concentrations of anti-Aβ autoantibodies. This autoinflammatory reaction is temporally and regionally associated with microglial activation, inflammation and radiological presence of vasogenic edema. Clinical characteristics include progressive demential development as well as headache and epileptic seizures. In the absence of histopathologic confirmation, the criteria defined by Auriel et al. allow diagnosis of probable resp. possible CAA-ri. CAA-ri shows responsiveness to immunosuppressive therapies and a possible coexistence with other autoinflammatory diseases. We present a case report and literature review on the diagnosis of CAA-ri in a patient with known granulomatosis with polyangiitis (GPA). Initially, the presented patient showed neuropsychiatric abnormalities and latent arm paresis. Due to slight increase in CSF cell count, an initial antiviral therapy was started. MR tomography showed a pronounced frontotemporal edema as well as cerebral microhemorrhages, leading to the diagnosis of CAA-ri. Subsequent high-dose steroid treatment followed by six intravenous cyclophosphamide pulses resulted in decreased CSF cell count and regression of cerebral MRI findings. The symptoms observed in the patient are consistent with previous case reports on CAA-ri. Due to previously known GPA, we considered a cerebral manifestation of this disease as a differential diagnosis. However, absence of pachymeningitis as well as granulomatous infiltrations on imaging made cerebral GPA less likely. An increased risk for Aβ-associated pathologies in systemic rheumatic diseases is discussed variously.
Sections du résumé
Background
UNASSIGNED
Cerebral amyloid angiopathy-related inflammation (CAA-ri) defines a subacute autoimmune encephalopathy, which is presumably caused by increased CSF concentrations of anti-Aβ autoantibodies. This autoinflammatory reaction is temporally and regionally associated with microglial activation, inflammation and radiological presence of vasogenic edema. Clinical characteristics include progressive demential development as well as headache and epileptic seizures. In the absence of histopathologic confirmation, the criteria defined by Auriel et al. allow diagnosis of probable resp. possible CAA-ri. CAA-ri shows responsiveness to immunosuppressive therapies and a possible coexistence with other autoinflammatory diseases.
Methods
UNASSIGNED
We present a case report and literature review on the diagnosis of CAA-ri in a patient with known granulomatosis with polyangiitis (GPA).
Results
UNASSIGNED
Initially, the presented patient showed neuropsychiatric abnormalities and latent arm paresis. Due to slight increase in CSF cell count, an initial antiviral therapy was started. MR tomography showed a pronounced frontotemporal edema as well as cerebral microhemorrhages, leading to the diagnosis of CAA-ri. Subsequent high-dose steroid treatment followed by six intravenous cyclophosphamide pulses resulted in decreased CSF cell count and regression of cerebral MRI findings.
Conclusion
UNASSIGNED
The symptoms observed in the patient are consistent with previous case reports on CAA-ri. Due to previously known GPA, we considered a cerebral manifestation of this disease as a differential diagnosis. However, absence of pachymeningitis as well as granulomatous infiltrations on imaging made cerebral GPA less likely. An increased risk for Aβ-associated pathologies in systemic rheumatic diseases is discussed variously.
Identifiants
pubmed: 38020617
doi: 10.3389/fneur.2023.1277843
pmc: PMC10666051
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1277843Informations de copyright
Copyright © 2023 Seifert, Rauch, Klingebiel, Boese, Greeve, Rudwaleit and Schäbitz.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Alzheimers Dis. 2012;31(3):669-76
pubmed: 22647255
Alzheimer Dis Assoc Disord. 2021 Jul-Sep 01;35(3):265-268
pubmed: 33480610
Neurology. 2011 Mar 1;76(9):772-3
pubmed: 21357829
Front Neurol. 2015 Sep 25;6:207
pubmed: 26441825
Front Neurol. 2019 Dec 06;10:1283
pubmed: 31866934
J Alzheimers Dis. 2016;51(2):525-32
pubmed: 26890776
Dis Markers. 2020 Dec 16;2020:8847306
pubmed: 33488845
N Engl J Med. 2014 Jan 23;370(4):322-33
pubmed: 24450891
Alzheimers Dement. 2011 Jul;7(4):367-85
pubmed: 21784348
Ann Neurol. 2013 Apr;73(4):449-58
pubmed: 23625526
Neurology. 2021 Nov 2;97(18):e1809-e1822
pubmed: 34531298
PLoS One. 2016 Dec 20;11(12):e0168106
pubmed: 27997574
Lancet Neurol. 2012 Mar;11(3):241-9
pubmed: 22305802
J Alzheimers Dis. 2015;46(4):1071-7
pubmed: 26402633
Alzheimers Dement (N Y). 2018 Sep 06;4:575-590
pubmed: 30406177
PLoS One. 2021 Mar 12;16(3):e0248395
pubmed: 33711047
J Alzheimers Dis. 2015;45(2):363-7
pubmed: 25537009
J Neuroinflammation. 2008 Aug 29;5:37
pubmed: 18759972
JAMA Neurol. 2016 Feb;73(2):197-202
pubmed: 26720093
Rheumatology (Oxford). 2019 Aug 1;58(8):1503-1505
pubmed: 30927437
J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):20-6
pubmed: 20935328
Neurology. 1996 Jun;46(6):1592-6
pubmed: 8649554
Semin Arthritis Rheum. 2014 Aug;44(1):86-92
pubmed: 24636849
Neurology. 2022 Sep 20;99(12):e1265-e1277
pubmed: 35940900
Rheumatology (Oxford). 2015 Mar;54(3):424-32
pubmed: 25187644
JAMA Neurol. 2020 Oct 1;77(10):1261-1269
pubmed: 32568365
Neurology. 2009 Sep 8;73(10):768-74
pubmed: 19738171
Drugs Aging. 2015 Feb;32(2):139-47
pubmed: 25644018
Neurology. 2016 Mar 8;86(10):912-9
pubmed: 26850981
Cells. 2021 Mar 07;10(3):
pubmed: 33799927
J Neurol Sci. 2002 Mar 30;195(2):161-6
pubmed: 11897248
Neurology. 2011 Mar 1;76(9):842-4
pubmed: 21357837
AJR Am J Roentgenol. 2015 Dec;205(6):W619-29
pubmed: 26587951
Int J Surg Case Rep. 2018;48:95-100
pubmed: 29883923